GRI
GRI Bio, Inc.
-0.05 (-2.49%)1.77USD105K成交股數3.9M市值0.0本益比(近四季)227.0股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | 16K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 407K | 361K | 1.8M | 1.9M | 1.6M | 833K | 1.1M | 877K | 933K | 1.2M | 880K | 116K |
| 銷售管理費用 | 1.2M | 1.6M | 1.6M | 1.0M | 1.4M | 1.1M | 1.0M | 1.4M | 962K | 1.3M | 5.1M | 872K |
| 營業利益 | −1.6M-46% | −2.0M+3% | −3.4M+58% | −2.9M+28% | −3.1M+61% | −2.0M-20% | −2.1M-64% | −2.3M+128% | −1.9M | −2.4M | −5.9M | −988K |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | -6,175.0% |
| 稅後淨利 | −1.6M-46% | −2.0M+3% | −3.4M+58% | −2.9M+29% | −3.0M+61% | −1.9M-9% | −2.1M-69% | −2.3M+5% | −1.9M | −2.1M | −6.7M | −2.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | -13,437.5% |
| 稀釋 EPS | -0.91-99% | -1.61-100% | -1.28-89% | -36.72-41% | -162.30+61% | -1371.23+1985% | -11.42-95% | -61.85+311% | -101.05 | -65.78 | -239.37 | -15.04 |
| 稀釋股數 | 1.8M | 1.2M | 2.6M | 78.8K | 18.8K | 6.5K | 186K | 36.4K | 18.7K | 32.5K | 28.2K | 143K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 10.9M | 11.0M | 4.1M | 5.1M | 3.3M | 5.0M | 4.7M | 6.4M | 4.1M | 3.5M | 4.8M | 1.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.4M | 11.3M | 4.8M | 5.7M | 4.0M | 5.7M | 5.5M | 7.0M | 4.6M | 4.4M | 5.6M | 2.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.1M | 794K | 2.8M | 2.4M | 2.8M | 1.7M | 1.8M | 2.3M | 1.8M | 2.2M | 1.6M | 2.1M |
| 股東權益 | 10.3M | 10.5M | 2.0M | 3.3M | 1.2M | 4.0M | 3.7M | 4.7M | 2.8M | 2.2M | 4.0M | −3.2M |
| 負債比 | 9.7% | 7.0% | 58.3% | 41.5% | 70.2% | 29.7% | 33.0% | 32.9% | 39.0% | 49.4% | 28.4% | 98.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.7M | – | – | −1.7M-21% | – | – | – | −2.2M | – | – | −579K |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −12.0M | –% | -121.80 | −10.2M |
| FY2024 | – | – | −8.2M | –% | -1545.55 | −8.6M |
| FY2023 | – | – | −13.0M | –% | -5018.09 | −9.0M |
| FY2022 | – | – | −3.2M | –% | -24.95 | −1.1M |
| FY2021 | 0.00 | -100.0% | −9.3M | –% | -1.42 | −8.3M |
| FY2020 | 100K | – | −4.8M | -4,822.0% | -1.07 | −3.7M |